HealthcareServices

Global Monkey Pox Testing Market Set for Strong Expansion, Reaching $1.88 Billion With 4.3% CAGR by 2030

February 26, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the monkey pox testing market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Monkey Pox Testing Market size between 2026 and 2035?

The monkey pox testing market size has demonstrated consistent expansion in recent years. This market is projected to expand from $1.52 billion in 2025 to $1.59 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 4.4%. Key factors driving its historical growth include the global dissemination experienced during the 2022 outbreak, coupled with limited diagnostic capabilities, reliance on centralized laboratory facilities, a notable shortage of test kits, and delays in case detection.

The monkey pox testing market is projected to experience consistent expansion in the coming years, with its value anticipated to reach $1.88 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.3%. This anticipated growth during the forecast period can be linked to several factors, including an increase in molecular testing capacity, the growing embrace of point-of-care diagnostics, elevated government surveillance efforts, an increase in research funding, and the advancement of rapid antigen technologies. Key trends expected during this period encompass the broadening of advanced molecular diagnostic platforms, the incorporation of AI for outbreak prediction and case mapping, an expansion of IoT-enabled remote testing infrastructure, the creation of high-throughput automated testing systems, and greater integration of cloud-based laboratory data networks.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18817&type=smp

Which Drivers Are Impacting Market Performance In The Monkey Pox Testing Market?

The rising occurrence of monkeypox disease is anticipated to fuel the expansion of the monkey pox testing market moving forward. Monkeypox is an uncommon viral illness resulting from the monkeypox virus, a part of the orthopoxvirus genus and linked to the smallpox virus. The surge in monkeypox incidents stems from elevated human-to-human transmission, increased international travel, and diminished immunity due to the cessation of smallpox vaccination initiatives. Monkeypox testing is crucial for early detection of infected individuals, facilitating prompt treatment and isolation to stop further dissemination of the illness. It additionally contributes to monitoring outbreaks and comprehending the virus’s spread dynamics. As an illustration, in September 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported 1,131 new confirmed cases of mpox and five additional related deaths between 14 August 2023 and 11 September 2023. Consequently, the growing prevalence of monkeypox disease is propelling the development of the monkey pox testing market.

What Segment Types Are Examined In The Monkey Pox Testing Market?

The monkey pox testing market covered in this report is segmented –

1) By Technology: Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Other Technologies

2) By Mode: Laboratory Testing, Point Of Care Testing

3) By End-Use: Hospitals And Clinics, Diagnostic Laboratories, Other End-Uses

Subsegments:

1) By Polymerase Chain Reaction (PCR): Real-Time PCR (qPCR), Reverse Transcription PCR (RT-PCR), Multiplex PCR

2) By Lateral Flow Assay (LFA): Immunochromatographic Lateral Flow Assays, Rapid Antigen Detection Kits

3) By Other Technologies: Enzyme-Linked Immunosorbent Assay (ELISA), CRISPR-Based Testing, Serological Tests (Antibody Detection)

Which Trends Are Shaping Activity Within The Monkey Pox Testing Market?

Leading companies in the monkey pox testing market are prioritizing the development of advanced solutions, such as lyophilised component RT PCR kits, to improve the accessibility and reliability of diagnostics. Lyophilised component technology involves freeze-drying reagents, allowing them to remain stable at ambient temperatures and be transported without requiring cold chain logistics. This approach reduces dependence on cold storage and facilitates deployment in remote areas, all while maintaining the accuracy and dependability of tests. For instance, in August 2024, Andhra Pradesh MedTech Zone (AMTZ), an India-based facility, in collaboration with Transasia Diagnostics, introduced the ErbaMDx Monkeypox RT-PCR Kit. This kit features lyophilised reagents and received validation from the Indian Council for Medical Research (ICMR) as well as emergency authorization from the Central Drugs Standard Control Organisation (CDSCO). The kit provides a 12 month shelf life and demonstrates zero cross reactivity with other orthopoxviruses, ensuring highly specific detection. It permits storage and transport at ambient temperature, making it ideal for remote and resource-limited settings. This kit significantly strengthens India’s epidemic preparedness by offering precise, reliable, and accessible mpox diagnosis, even in regions without cold chain infrastructure.

Who Are The Core Companies Influencing Trends In The Monkey Pox Testing Market?

Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/monkey-pox-testing-global-market-report

Which Region Is Projected To Lead The Monkey Pox Testing Market During The Forecast Period?

North America was the largest region in the monkey pox testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Monkey Pox Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18817&type=smp

Browse Through More Reports Similar to the Global Monkey Pox Testing Market 2026, By The Business Research Company

Non Animal Alternatives Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-animal-alternatives-testing-global-market-report

Monkey Pox Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report

Infectious Disease Diagnostics Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795